Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,441 | 84 | 68.3% |
| Current or prospective ownership or investment interest | $668.93 | 1 | 31.7% |
| Unspecified | $0 | 1 | 0.0% |
Payments by Type
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Physician Discoveries, LLC | $668.93 | 2 | $0 (2017) |
| Astellas Pharma US Inc | $349.58 | 26 | $0 (2019) |
| NeoTract Inc. | $154.18 | 5 | $0 (2017) |
| Sumitomo Pharma America, Inc. | $148.67 | 8 | $0 (2024) |
| Boston Scientific Corporation | $106.60 | 5 | $0 (2024) |
| ABBVIE INC. | $85.62 | 5 | $0 (2024) |
| Janssen Biotech, Inc. | $73.48 | 3 | $0 (2024) |
| Teleflex LLC | $64.23 | 2 | $0 (2024) |
| PFIZER INC. | $55.88 | 4 | $0 (2024) |
| Amgen Inc. | $46.50 | 3 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $542.25 | 26 | Sumitomo Pharma America, Inc. ($148.67) |
| 2023 | $21.64 | 1 | Boston Scientific Corporation ($21.64) |
| 2021 | $34.85 | 1 | Teleflex LLC ($34.85) |
| 2019 | $45.47 | 2 | Astellas Pharma US Inc ($22.92) |
| 2018 | $203.61 | 15 | Astellas Pharma US Inc ($108.61) |
| 2017 | $1,262 | 41 | Physician Discoveries, LLC ($668.93) |
All Payment Transactions
86 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/05/2024 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $27.55 | General |
| Category: HORMONE THERAPY | ||||||
| 11/17/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $16.10 | General |
| Category: UROLOGY | ||||||
| 10/17/2024 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $20.49 | General |
| Category: Oncology | ||||||
| 10/16/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $21.61 | General |
| Category: UROLOGY | ||||||
| 10/03/2024 | Endo USA, Inc. | AVEED (Biological), XIAFLEX | Food and Beverage | In-kind items and services | $14.10 | General |
| Category: UROLOGY | ||||||
| 09/11/2024 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $34.52 | General |
| Category: Oncology | ||||||
| 08/08/2024 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $18.47 | General |
| Category: Oncology | ||||||
| 07/25/2024 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $27.57 | General |
| Category: HORMONE THERAPY | ||||||
| 07/25/2024 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug) | Food and Beverage | In-kind items and services | $16.74 | General |
| Category: Oncology | ||||||
| 07/18/2024 | Endo USA, Inc. | AVEED (Biological), XIAFLEX | Food and Beverage | In-kind items and services | $14.10 | General |
| Category: UROLOGY | ||||||
| 07/11/2024 | Boston Scientific Corporation | SpaceOAR VUE System - 10mL (Device) | Food and Beverage | In-kind items and services | $29.40 | General |
| Category: SpaceOAR VUE_URO | ||||||
| 07/11/2024 | Boston Scientific Corporation | SpaceOAR VUE System - 10mL (Device) | Food and Beverage | In-kind items and services | $29.40 | General |
| Category: SpaceOAR VUE_URO | ||||||
| 07/11/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $19.43 | General |
| Category: UROLOGY | ||||||
| 06/06/2024 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $19.43 | General |
| Category: HORMONE THERAPY | ||||||
| 05/31/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $22.76 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 05/30/2024 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug) | Food and Beverage | In-kind items and services | $24.40 | General |
| Category: Oncology | ||||||
| 05/09/2024 | ABC Home Medical Supply, Inc. | — | Food and Beverage | In-kind items and services | $18.26 | General |
| 04/26/2024 | PFIZER INC. | XTANDI (Drug), ORGOVYX, TALZENNA | Food and Beverage | In-kind items and services | $21.96 | General |
| Category: ONCOLOGY | ||||||
| 04/04/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $15.72 | General |
| Category: UROLOGY | ||||||
| 04/03/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $1.26 | General |
| Category: UROLOGY | ||||||
| 03/20/2024 | Endo Pharmaceuticals Inc. | AVEED (Biological), XIAFLEX | Food and Beverage | In-kind items and services | $14.10 | General |
| Category: UROLOGY | ||||||
| 03/13/2024 | Merck Sharp & Dohme LLC | LYNPARZA (Biological) | Food and Beverage | In-kind items and services | $27.07 | General |
| Category: ONCOLOGY | ||||||
| 03/08/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $24.22 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 02/28/2024 | Teleflex LLC | UROLIFT (Device) | Food and Beverage | In-kind items and services | $29.38 | General |
| Category: INTERVENTIONAL UROLOGY | ||||||
| 02/15/2024 | UROGEN PHARMA, INC. | JELMYTO (Drug) | Food and Beverage | In-kind items and services | $20.11 | General |
| Category: UROTHELIAL CANCER | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 207 | 233 | $30,360 | $12,623 |
| 2022 | 4 | 112 | 130 | $15,272 | $7,788 |
| 2021 | 16 | 1,190 | 1,865 | $335,290 | $79,516 |
| 2020 | 23 | 946 | 3,202 | $586,129 | $101,316 |
All Medicare Procedures & Services
49 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 75 | 91 | $9,827 | $4,345 | 44.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 33 | 40 | $5,960 | $2,687 | 45.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Facility | 2023 | 36 | 36 | $5,435 | $1,940 | 35.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 18 | 18 | $4,264 | $1,712 | 40.1% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Facility | 2023 | 21 | 24 | $3,395 | $1,365 | 40.2% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Facility | 2023 | 24 | 24 | $1,479 | $575.74 | 38.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 26 | 32 | $4,203 | $2,369 | 56.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 33 | 42 | $3,741 | $2,109 | 56.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Facility | 2022 | 36 | 36 | $4,528 | $2,097 | 46.3% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Facility | 2022 | 17 | 20 | $2,800 | $1,212 | 43.3% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 287 | 425 | $85,425 | $26,640 | 31.2% |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | Office | 2021 | 19 | 148 | $120,620 | $19,588 | 16.2% |
| 52000 | Diagnostic examination of the bladder and bladder canal (urethra) using an endoscope | Office | 2021 | 48 | 65 | $46,800 | $11,110 | 23.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 93 | 124 | $36,084 | $10,676 | 29.6% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 27 | 27 | $11,907 | $3,120 | 26.2% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 32 | 32 | $9,216 | $2,689 | 29.2% |
| 81001 | Manual urinalysis test with examination using microscope, automated | Office | 2021 | 213 | 348 | $4,176 | $1,103 | 26.4% |
| 74176 | Ct scan of abdomen and pelvis | Office | 2021 | 11 | 12 | $4,500 | $1,022 | 22.7% |
| 96402 | Hormonal anti-neoplastic chemotherapy administration beneath the skin or into muscle | Office | 2021 | 22 | 34 | $3,638 | $797.76 | 21.9% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2021 | 152 | 200 | $2,200 | $600.00 | 27.3% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2021 | 34 | 55 | $2,695 | $534.87 | 19.8% |
| 74018 | X-ray of abdomen, 1 view | Office | 2021 | 17 | 21 | $2,079 | $479.64 | 23.1% |
| 81003 | Automated urinalysis test | Office | 2021 | 157 | 210 | $1,680 | $468.68 | 27.9% |
| 74420 | Imaging of urinary tract | Facility | 2021 | 13 | 17 | $1,530 | $333.71 | 21.8% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2021 | 44 | 51 | $2,397 | $317.34 | 13.2% |
About Dr. Marshall Hall, MD
Dr. Marshall Hall, MD is a Urology healthcare provider based in Rockport, Maine. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/18/2005. The National Provider Identifier (NPI) number assigned to this provider is 1881676484.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Marshall Hall, MD has received a total of $2,110 in payments from pharmaceutical and medical device companies, with $542.25 received in 2024. These payments were reported across 86 transactions from 27 companies. The most common payment nature is "Food and Beverage" ($1,441).
As a Medicare-enrolled provider, Hall has provided services to 2,455 Medicare beneficiaries, totaling 5,430 services with total Medicare billing of $201,243. Data is available for 4 years (2020–2023), covering 49 distinct procedure/service records.
Practice Information
- Specialty Urology
- Other Specialties Urology
- Location Rockport, ME
- Active Since 11/18/2005
- Last Updated 02/15/2024
- Taxonomy Code 208800000X
- Entity Type Individual
- NPI Number 1881676484
Products in Payments
- Myrbetriq (Drug) $187.24
- Urolift - UL400 (Device) $154.18
- XTANDI (Drug) $91.32
- SpaceOAR VUE System - 10mL (Device) $80.44
- ORGOVYX (Drug) $74.55
- GEMTESA (Drug) $74.12
- ERLEADA (Drug) $73.48
- MYRBETRIQ (Drug) $62.78
- BOTOX (Biological) $46.98
- Prolia (Biological) $46.50
- AVEED (Biological) $42.30
- Nubeqa (Drug) $41.14
- Androgel (Drug) $38.64
- UroLift System (Device) $34.85
- Xtandi (Drug) $30.81
- UROLIFT (Device) $29.38
- LYNPARZA (Biological) $27.07
- PROVENGE (Drug) $27.05
- XIAFLEX (Biological) $24.73
- CRESEMBA (Drug) $22.92
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Urology Doctors in Rockport
Robert Fisher, Md, MD
Urology — Payments: $7,057
Dr. Sara Valente, M.d, M.D
Urology — Payments: $3,286
Dr. Elizabeth Albertson, Md, MD
Urology — Payments: $2,282
Lars Ellison, Md, MD
Urology — Payments: $358.55
Martyn Vickers, M.d, M.D
Urology